|The MAP1A map1a (Catalog #MBS2524528) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The MAP1A Polyclonal Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s MAP1A can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC).
IHC: 1:25-1:100. Researchers should empirically determine the suitability of the MAP1A map1a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The MAP1A map1a product has the following accession number(s) (GI #95147555) (NCBI Accession #NP_002364.5). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the MAP1A Polyclonal Antibody with the following immunoassay(s):
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human ovarian cancer tissue using MAP1A Polyclonal Antibody at dilution 1:25)
Immunohistochemistry (IHC) (Immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using MAP1A Polyclonal Antibody at dilution 1:25)
This gene encodes a protein that belongs to the microtubule-associated protein family. The proteins of this family are thought to be involved in microtubule assembly, which is an essential step in neurogenesis. The product of this gene is a precursor polypeptide that presumably undergoes proteolytic processing to generate the final MAP1A heavy chain and LC2 light chain. Expression of this gene is almost exclusively in the brain. Studies of the rat microtubule-associated protein 1A gene suggested a role in early events of spinal cord development.
Immunogen: Synthetic peptide of human MAP1A. Buffer: PBS with 0.05% sodium azide, 50% glycerol, pH7.3. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing MAP1A are readily searchable from our website. Different antibodies against the same target such as MAP1A may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Bone, Brain, Embryonic Tissue, Eye, Kidney, Liver, Muscle, Nerve, Spinal Cord, Testis tissues are correlated with this protein. MAP1A also interacts with the following gene(s): KCNMA1, MAP1B, RAPGEF3. Brain Diseases, Cardiovascular Diseases, Disease Models, Animal, Mental Disorders, Mood Disorders, Movement Disorders, Nerve Degeneration, Nervous System Diseases, Neurobehavioral Manifestations, Stroke are some of the diseases may be linked to MAP1A Polyclonal Antibody.